OMEROS CORP Income (Loss) from Continuing Operations, Per Basic Share
OMEROS CORP (OMER) reported Income (Loss) from Continuing Operations, Per Basic Share of $0.09 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2026-08-12
- OMEROS CORP income (loss) from continuing operations, per basic share for the quarter ending 2026-06-30 was $0.09.
- OMEROS CORP income (loss) from continuing operations, per basic share for the quarter ending 2026-03-31 was $0.71.
- OMEROS CORP income (loss) from continuing operations, per basic share for the quarter ending 2025-09-30 was -$0.32.
- OMEROS CORP income (loss) from continuing operations, per basic share for the quarter ending 2025-06-30 was -$0.44.
- OMEROS CORP income (loss) from continuing operations, per basic share for fiscal 2025 was -$0.08.
- OMEROS CORP income (loss) from continuing operations, per basic share for fiscal 2024 was -$3.14.
- OMEROS CORP income (loss) from continuing operations, per basic share for fiscal 2023 was -$2.79.
- OMEROS CORP income (loss) from continuing operations, per basic share for fiscal 2022 was -$2.90.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 3 month | Income (Loss) from Continuing Operations, Per Basic Share 6 month | Income (Loss) from Continuing Operations, Per Basic Share 9 month | Income (Loss) from Continuing Operations, Per Basic Share 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.09 10-Q · filed 2026-08-12 | $0.80 10-Q · filed 2026-08-12 | ||
| 2026-03-31 | $0.71 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | -$0.08 10-K · filed 2026-03-31 | |||
| 2025-09-30 | -$0.32 10-Q · filed 2025-11-13 | -$1.39 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | -$0.44 10-Q · filed 2026-08-12 | -$1.09 10-Q · filed 2026-08-12 | ||
| 2025-03-31 | -$0.65 10-Q · filed 2026-05-13 | |||
| 2024-12-31 | -$3.14 10-K · filed 2026-03-31 | |||
| 2024-09-30 | -$0.64 10-Q · filed 2025-11-13 | -$2.51 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | -$1.12 10-Q · filed 2025-08-14 | -$1.87 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | -$0.75 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | -$2.79 10-K · filed 2026-03-31 | |||
| 2023-09-30 | -$0.82 10-Q · filed 2024-11-13 | -$2.16 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | -$0.70 10-Q · filed 2024-08-07 | -$1.34 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | -$0.63 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | -$2.90 10-K · filed 2025-03-31 | |||
| 2022-09-30 | -$0.87 10-Q · filed 2023-11-09 | -$2.17 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | -$0.66 10-Q · filed 2023-08-09 | -$1.30 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | -$0.63 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | -$3.07 10-K · filed 2024-04-01 | |||
| 2021-09-30 | -$0.70 10-Q · filed 2022-11-09 | -$2.32 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | -$0.80 10-Q · filed 2022-08-09 | -$1.61 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | -$0.81 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | -$3.02 10-K · filed 2023-03-13 | |||
| 2019-12-31 | -$2.98 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |